Table 2.
Estimate | Standard Error | p value | ||
---|---|---|---|---|
Intercept | −0.833 | 0.334 | 0.0126 | |
African continental ancestry | 0.432 | 0.250 | 0.0838 | |
rs10529326 | TMCO1 | 0.364 | 0.073 | 5.4×10−7 |
rs2432663 | CYP1B1 | 0.476 | 0.119 | 6.3×10−5 |
rs199612704 | FNDC3B | 0.818 | 0.163 | 4.9×10−7 |
rs4328916 | AFAP1 | 0.197 | 0.048 | 4.3×10−5 |
rs7009228 | 8q22 | 0.259 | 0.051 | 5.1×10−7 |
rs2383204 | 9p21#1 | 0.232 | 0.051 | 4.9×10−6 |
rs79721419 | 9p21#2 | 0.616 | 0.151 | 4.5×10−4 |
rs551169 | ABO | 0.196 | 0.046 | 1.7×10−5 |
rs8080535 | GAS7 | 0.159 | 0.047 | 0.00071 |
rs235902 | MYOC | 0.174 | 0.067 | 0.0092 |
rs1332985 | PMM2 | 0.104 | 0.053 | 0.050 |
The genotypes of those SNPs in Table 1 with negative effect sizes were re-coded to the other allele so that the number of alleles for each SNP was additive for increased POAG risk. All SNPs were then combined into a single logistic regression model. AD for each subject was estimated using Admixture 1.3.0 with K=3 on a subset of the genotyping data pruned for linkage disequilibrium. The dataset for this table, with genotypes coded to be additive, was then used to create Genetic Risk Score #1. Note that both 9p21 SNPs, rs2383204 and rs79721419, remained in this model, further supporting their statistical independence.